Post by Bio Base Europe Pilot Plant

22,478 followers

๐ŸŒฑ ๐Ÿงฌ ๐—ช๐—ต๐—ฎ๐˜ ๐—ถ๐—ณ ๐—ฐ๐—ฟ๐—ผ๐—ฝ ๐—ฝ๐—ฟ๐—ผ๐˜๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฑ๐—ถ๐—ฑ๐—ปโ€™๐˜ ๐—ฟ๐—ฒ๐—น๐˜† ๐—ผ๐—ป ๐—ฐ๐—ต๐—ฒ๐—บ๐—ถ๐—ฐ๐—ฎ๐—น๐˜€ ๐—ฎ๐˜ ๐—ฎ๐—น๐—น, ๐—ฏ๐˜‚๐˜ ๐—ผ๐—ป ๐—ฝ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป๐˜€ ๐—ฑ๐—ฒ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฑ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—น๐—น๐—ฎ๐—บ๐—ฎ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฐ๐—ฎ๐—บ๐—ฒ๐—น๐˜€? ๐ŸŽ™ Episode 8 of our ๐๐ข๐ญ๐œ๐ก ๐๐ž๐ซ๐Ÿ๐ž๐œ๐ญ ๐— ๐›๐ข๐จ๐‚๐ข๐ซ๐œ๐ฎ๐ฅ๐š๐ซ ๐‹๐จ๐จ๐ฉ: ๐–๐ก๐š๐ญ ๐ข๐ญ ๐ญ๐š๐ค๐ž๐ฌ ๐ญ๐จ ๐ฌ๐œ๐š๐ฅ๐ž ๐›๐ข๐จ-๐›๐š๐ฌ๐ž๐ ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž miniseries is now live. Recorded at the Pitch Perfect and Boost the European Bioeconomy event in Brussels, this episode brings the deep-tech scale-up perspective into the discussion on ๐˜„๐—ต๐—ฎ๐˜ ๐—ถ๐˜ ๐˜๐—ฎ๐—ธ๐—ฒ๐˜€ ๐˜๐—ผ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐—ฐ๐—ต๐—ฒ๐—บ๐—ถ๐—ฐ๐—ฎ๐—น ๐—ถ๐—ป๐—ฐ๐˜‚๐—บ๐—ฏ๐—ฒ๐—ป๐˜๐˜€ ๐—ถ๐—ป ๐—ฎ๐—ด๐—ฟ๐—ถ๐—ฐ๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ. Melina Gerdts' guest is Bart Walcarius, Head of Technology Integration at Biotalys, a company developing ๐—ฝ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป-๐—ฏ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฏ๐—ถ๐—ผ๐—ฐ๐—ผ๐—ป๐˜๐—ฟ๐—ผ๐—น๐˜€ as alternatives to conventional chemical pesticides. Biotalys engineers small, highly specific proteins derived from camel and alpaca antibodies. These proteins are ๐—ฏ๐—ถ๐—ผ๐—ฑ๐—ฒ๐—ด๐—ฟ๐—ฎ๐—ฑ๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ฑ๐—ฒ๐˜€๐—ถ๐—ด๐—ป๐—ฒ๐—ฑ ๐˜๐—ผ ๐—ฝ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ฒ๐—น๐˜† ๐˜๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ ๐—ฐ๐—ฟ๐—ผ๐—ฝ ๐—ฝ๐—ฒ๐˜€๐˜๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฑ๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ๐˜€ ๐˜„๐—ถ๐˜๐—ต๐—ผ๐˜‚๐˜ ๐—น๐—ฒ๐—ฎ๐˜ƒ๐—ถ๐—ป๐—ด ๐—ต๐—ฎ๐—ฟ๐—บ๐—ณ๐˜‚๐—น ๐—ฟ๐—ฒ๐˜€๐—ถ๐—ฑ๐˜‚๐—ฒ๐˜€. The conversation goes into what scaling really looks like in agricultural biotech: ๐Ÿ”„ Competing against cheap chemical pesticides means cost of goods is critical from day one. Precision fermentation must be economically viable at scale. ๐Ÿ”„ Strain development is only the beginning. Host selection, expression optimisation, and scalable process design take years, not months. ๐Ÿ”„ Scaling requires external partnerships early, from pilot facilities like Bio Base Europe Pilot Plant to large-scale contract manufacturers. ๐Ÿ”„ Regulatory approval is a defining milestone. The EPA in the US has issued a proposed registration decision for Biotalysโ€™ first biofungicide, a major validation step. ๐Ÿ”„ Europe moves more slowly. EFSA approval will take one to two more years. Regulatory timing directly shapes market entry strategy. ๐Ÿ”„ Multidisciplinary teams are essential. Molecular biology, fermentation engineering, regulatory expertise, agronomy and manufacturing all need to work together. ๐Ÿ”„ Scaling bio-based innovation is not only a technical challenge. It is a coordination challenge across science, manufacturing and regulation. This episode shows what happens when bio-based innovation meets one of the toughest markets in the world: crop protection. ๐Ÿ“บ Video podcast available on YouTube ๐ŸŽง Audio version available on Spotify ๐Ÿ‘‰ Follow bioCircular Loop and Bio Base Europe Pilot Plant to catch the next episode and stay informed on how bio-based innovation moves from lab science to field application. #bioeconomy #biotech #agriculture #biocontrol #scaling #innovation #circulareconomy #PitchPerfect

Post content

Video Content